Skip to main content
SpringerLink
Log in

Hypertension in End-Stage Renal Disease

  • Chapter
  • First Online:
Pediatric Hypertension

Part of the book series: Clinical Hypertension and Vascular Diseases ((CHVD))

Abstract

Hypertension is a frequent finding in children with end-stage renal disease (ESRD), occurring more often than in children with chronic kidney disease. The origin comes from the chronically diseased kidney (see preceding chapter), but additional risk factors appear in dialyzed and transplanted children, such as fluid overload, immunosuppressive drugs, or obesity. Hypertension is one of the most important risk factors for cardiovascular morbidity and mortality in children with ESRD. Furthermore, cardiovascular events are the most common cause of death in these patients. Therefore, the treatment of hypertension is one of the most important strategies in dialyzed and transplanted children to improve their survival.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Frauman AC, Lansing LM, Fennell RS. Indirect blood pressure measurement in undergoing hemodialysis: a comparison of brachial and dorsalis pedis auscultatory sites. AANNT J. 1984;11:19–21.

    PubMed  CAS  Google Scholar 

  2. Park MK, Lee DH, Johnson GA. Oscillometric blood pressures in the arm, thigh, and calf in healthy children and those with aortic coarctation. Pediatrics. 1993;91:761–765.

    PubMed  CAS  Google Scholar 

  3. Rahman M, Griffin V, Kumar A, Manzoor F, Wright FJ Jr, Smith MC. A comparison of standardized versus “usual” blood pressure measurements in hemodialysis patients. Am J Kidney Dis. 2002;39:1226–1230.

    Article  PubMed  Google Scholar 

  4. Menard SW, Park MK, Yuan CH. The San Antonio Biethnic Children’s Blood Pressure Study: auscultatory findings. J Pediatr Health Care. 1999;13:237–244.

    Article  PubMed  CAS  Google Scholar 

  5. Coomer RW, Schulman G, Breyer JA, Shyr Y. Ambulatory blood pressure monitoring in dialysis patients and estimation of mean interdialytic blood pressure. Am J Kidney Dis. 1997;29:678–684.

    Article  PubMed  CAS  Google Scholar 

  6. Luik AJ, Kooman P, Leuwissen KML. Hypertension in haemodialysis patients: is it only hypervolemia? Nephrol Dial Transplant. 1997;12:1557–1560.

    Article  PubMed  CAS  Google Scholar 

  7. Conion PJ, Walshe JJ, Heinle S. Predialysis systolic blood pressure correlates strongly with mean 24-hour systolic blood pressure and left ventricular mass in stable hemodialysis patients. J Am Soc Nephrol. 1996;7:2658–2663.

    PubMed  CAS  Google Scholar 

  8. Sankaranarayaan N, Santos SF, Peixoto AJ. Blood pressure measurement in dialysis patients. Adv Chron Kidney Dis. 2004;11:134–142.

    Article  Google Scholar 

  9. Ritz E, Schwenger V, Zeier M, Rychlik I. Ambulatory blood pressure monitoring: fancy gadgetry or clinically useful exercise? Nephrol Dial Transplant. 2001;16:1550–1554.

    Article  PubMed  CAS  Google Scholar 

  10. Koch VH, Furusawa EA, Ignes E, Okay Y, Mion Junior D. Ambulatory blood pressure monitoring in chronically dialyzed pediatric patients. Blood Press Monit. 1999;4:213–216.

    PubMed  CAS  Google Scholar 

  11. Lingens N, Soergel M, Loirat C, Busch D, Lemmer B, Schärer K. Ambulatory blood pressure monitoring in pediatric patients treated by regular haemodialysis and peritoneal dialysis. Pediatr Nephrol. 1995;9:167–172.

    Article  PubMed  CAS  Google Scholar 

  12. Peixoto AJ, Santos SF, Mendes RB, Crowley ST, Maldonado R, Orias M, Mansoor GA, White WB. Am J Kidney Dis. 2000;36:983–990.

    Article  PubMed  CAS  Google Scholar 

  13. Sorof JM, Brewer ED, Portman RJ. Ambulatory blood pressure monitoring and interdialytic weight gain in children receiving chronic hemodialysis. Am J Kidney Dis. 1999;33:667–674.

    Article  PubMed  CAS  Google Scholar 

  14. Covic A, Goldsmith D. Ambulatory blood pressure monitoring: an essential tool for blood pressure assessment in uraemic patients. Nephrol Dial Transplant. 2002;17:1737–1741.

    Article  PubMed  Google Scholar 

  15. Peixoto AJ, White WB. Ambulatory blood pressure monitoring in chronic renal disease: technical aspects and clinical relevance. Curr Opin Nephrol Hypertens. 2002;11:507–516.

    Article  PubMed  Google Scholar 

  16. Sorof JM. Ambulatory blood pressure monitoring in pediatric end-stage renal disease: chronic dialysis and transplantation. Blood Press Monit. 1999;4:171–174.

    PubMed  CAS  Google Scholar 

  17. Bald M, Böhm W, Feldhoff C, Bonzel KE. Home blood pressure self-measurement in children and adolescents with renal replacement therapy. Klin Padiatr. 2001;213:21–25.

    Article  PubMed  CAS  Google Scholar 

  18. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555–557.

    Article  Google Scholar 

  19. Soergel M, Kirschstein M, Busch C, Danne T, Gellermann J, Holl R, Krull F, Reichert H, Reusz GS, Rascher W. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr. 1997;130:178–184.

    Article  PubMed  CAS  Google Scholar 

  20. Schärer K, Rauh W, Ulmer HE. The management of hypertension in children with chronic renal failure. In: Giovannelli G, New MI, Gorini S, eds. Hypertension in Children and Adolescents. New York, NY: Raven; 1981:239–250.

    Google Scholar 

  21. Loirat C, Ehrich JH, Geerlings W, Jones EH, Landais P, Loirat C, Mallick NP, Margreiter R, Raine AE, Salmela K. Report on management of renal failure in Europe XXII, 1992. Nephrol Dial Transplant. 1994;9(Suppl 1):26–40.

    PubMed  Google Scholar 

  22. Lerner GR, Warady BA, Sullivan EK, Alexander SR. Chronic dialysis in children and adolescents. The 1996 report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol. 1999;13:404–417.

    Article  PubMed  CAS  Google Scholar 

  23. VanDeVoorde RG, Barletta GM, Chand DH, Dresner IG, Lane J, Leiser J, Lin JJ, Pan CG, Patel H, Valentini RP, Mitsnefes MM. Blood pressure control in pediatric hemodialysis: the Midwest pediatric nephrology consortium Study. Pediatr Nephrol. 2007;22:547–553.

    Article  PubMed  Google Scholar 

  24. Schaefer F, Klaus G, Müller-Wiefel D, Mehls O. Mid-European Pediatric Peritoneal Dialysis Study Group. Current practice of peritoneal dialysis in children: results of a longitudinal survey. Perit Dial Int. 1999;19:S445–S449.

    PubMed  Google Scholar 

  25. Mitsnefes MM, Stablein D. Hypertension in pediatric patients on long-term dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis. 2005;45:309–315.

    Article  PubMed  Google Scholar 

  26. Tkaczyk M, Nowicki M, Balasz-Chmielewska I, et al. Hypertension in dialysed children: the prevalence and therapeutic approach in Poland—a nationwide survey. Nephrol Dial Transplant. 2006;21:736–742.

    Article  PubMed  Google Scholar 

  27. Amar J, Vernier I, Rossignol E, Bongard V, Arnaud C, Conte JJ, Salvador M, Chamontin B. Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int. 2000;57:2485–2491.

    Article  PubMed  CAS  Google Scholar 

  28. Liu M, Takahashi H, Morita Y, Maruyama S, Mizumo M, Yuzawa Y, Watanabe M, Toriyama T, Kawahara H, Matsuo S. Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients. Nephrol Dial Transplant. 2003;18:563–569.

    Article  PubMed  Google Scholar 

  29. Holttä T, Happonen JM, Rönnholm K, Fyhrquist F, Holmberg C. Hypertension, cardiac state, and the role of volume overload during peritoneal dialysis. Pediatr Nephrol. 2001;16:324–331.

    Article  PubMed  Google Scholar 

  30. Guyton AC, Granger HJ, Coleman TG. Autoregulation of the total systemic circulation and its relation to control of cardiac output and arterial pressure. Circ Res. 1971;28(Suppl 1):93–97.

    PubMed  Google Scholar 

  31. Charra B, Bergstrom J, Scribner BH. Blood pressure control in dialysis patients: importance of the lag phenomenon. Am J Kidney Dis. 1998;32:720–724.

    Article  PubMed  CAS  Google Scholar 

  32. Katzarski KS, Charra B, Luik AJ, Nisell J, Divino Filho JC, Leypoldt JK, Leunissen KM, Laurent G, Bergström J. Fluid state and blood pressure control in patients treated with long and short hemodialysis. Nephrol Dial Transplant. 1999;14:369–375.

    Article  PubMed  CAS  Google Scholar 

  33. Hörl MP, Hörl WH. Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis. 2002;39:227–244.

    Article  PubMed  Google Scholar 

  34. Rauh W, Hund E, Sohl G, Rascher W, Mehls O, Schärer K. Vasoactive hormones in children with chronic renal failure. Kidney Int. 1983;24(Suppl 15):16–21.

    Google Scholar 

  35. Mailloux LU. Hypertension in chronic renal failure and ESRD: prevalence, pathophysiology, and outcomes. Semin Nephrol. 2001;21:146–156.

    Article  PubMed  CAS  Google Scholar 

  36. Orth SR, Amann K, Strojek K, Ritz E. Sympathetic overactivity and arterial hypertension in renal failure. Nephrol Dial Transplant. 2001;16(Suppl 1):67–69.

    PubMed  Google Scholar 

  37. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992;327:1912–1928.

    Article  PubMed  Google Scholar 

  38. Ritz E, Amann K, Törnig J, Schwartz U, Stein G. Some cardiac abnormalities in renal failure. Adv Nephrol. 1997;27:85–103.

    CAS  Google Scholar 

  39. Erkan E, Devarajan P, Kaskel F. Role of nitric oxide, endothelin-1, and inflammatory cytokines in blood pressure regulation in hemodialysis patients. Am J Kidney Dis. 2002;40:76–81.

    Article  PubMed  CAS  Google Scholar 

  40. Passauer J, Bussemaker E, Range U, Plug M, Gross P. Evidence in vivo showing increase of nitric oxide generation and impairment of endothelium dependent vasodilatation in normotensive patients on chronic hemodialysis. J Am Soc Nephrol. 2000;11:1726–1734.

    PubMed  CAS  Google Scholar 

  41. Xiao S, Wagner L, Schmidt RJ, Baylis C. Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease. Kidney Int. 2001;59:1466–1472.

    Article  PubMed  CAS  Google Scholar 

  42. Wang S, Vicente FB, Miller A, Brooks ER, Price HE, Smith FA. Measurement of arginine derivates in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med. 2007;45:1305–1312.

    Article  PubMed  CAS  Google Scholar 

  43. Menon MK, Naimark DM, Bargman JM, Vas SI, Oreopoulos DG. Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant. 2001;16:2207–2213.

    Article  PubMed  CAS  Google Scholar 

  44. Schärer K, Benninger C, Heimann A, Rascher W. Involvement of the central nervous system in renal hypertension. Eur J Pediatr. 1993;152:59–63.

    Article  PubMed  Google Scholar 

  45. Schärer K, Schmidt KG, Soergel M. Cardiac function and structure in patients with chronic renal failure. Pediatr Nephrol. 1999;13:951–965.

    Article  PubMed  Google Scholar 

  46. Colan SD, Sanders SP, Ingelfinger JR, Harmon W. Left ventricular mechanics and contractile state in children and young adults with end-stage renal disease: effect of dialysis and transplantation. J Am Coll Cardiol. 1987;10:1085–1094.

    Article  PubMed  CAS  Google Scholar 

  47. Goren A, Glaser I, Drukker A. Diastolic function in children and adolescents on dialysis and after kidney transplantation: an echocardiographic assessment. Pediatr Nephrol. 1993;7:725–728.

    Article  PubMed  CAS  Google Scholar 

  48. Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol. 2001;12:1079–1084.

    PubMed  CAS  Google Scholar 

  49. London GM. The concept of ventricular vascular coupling: functional and structural alterations of the hearth and arterial vessels of the heart go in parallel. Nephrol Dial Transplant. 1998;13:250–253.

    PubMed  CAS  Google Scholar 

  50. Mitsnefes MM, Daniels SR, Schwartz SM, Khoury P, Strife CF. Changes in left ventricular mass in children and adolescents during chronic dialysis. Pediatr Nephrol. 2001;16:318–325.

    Article  PubMed  CAS  Google Scholar 

  51. Mitsnefes MM, Barletta GM, Dresner IG, Chand DH, Geary D, Lin JJ, Patel H. Severe cardiac hypertrophy and long-term dialysis: the Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol. 2006;21:1167–1170.

    Article  PubMed  Google Scholar 

  52. De Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol. 1995;25:1056–1062.

    Article  PubMed  Google Scholar 

  53. Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF. Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol. 2000;14:898–902.

    Article  PubMed  CAS  Google Scholar 

  54. Washio M, Okuda S, Mizou CT, Mizoue T, Kiyama S, Ando T, Sanai T, Hirakata H, Nanishi F, Kiyohara C, Ogimoto I, Fujishima M. Risk factors for left ventricular hypertrophy in chronic hemodialysis patients. Clin Nephrol. 1997;47:362–366.

    PubMed  CAS  Google Scholar 

  55. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME. Alterations of left ventricular hypertrophy and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol. 2001;12:2759–2767.

    PubMed  CAS  Google Scholar 

  56. Chan CF, Floras JS, Miller JA, Richardson RM, Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int. 2002;61:2235–2239.

    Article  PubMed  Google Scholar 

  57. Ulinski T, Genty J, Viau C, Tillous-Borde I, Deschenes G. Reduction of left ventricular hypertrophy in children undergoing hemodialysis. Pediatr Nephrol. 2006;21:1171–1178.

    Article  PubMed  Google Scholar 

  58. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB. Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478–1483.

    Article  PubMed  CAS  Google Scholar 

  59. Oh J, Wunsch R, Turzer M, Bahner M, Raqqi P, Querfeld U, Mehls O, Schaefer F. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002;106:100–105.

    Article  PubMed  Google Scholar 

  60. Civilibal M, Caliskan S, Oflaz H, Sever L, Candan C, Canpolat N, Kasapcopur O, Bugra Z, Arisoy N. Traditional and “new” cardiovascular risk markers and factors in pediatric dialysis patients. Pediatr Nephrol. 2007;22:1021–1029.

    Article  PubMed  Google Scholar 

  61. Amar J, Vernier I, Rossignol E. Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int. 2000;57:2485–2491.

    Article  PubMed  CAS  Google Scholar 

  62. Foley RN, Herzog CA, Collins AJ. Blood pressure and long-term mortality in United States hemodialysis patients: USRDS waves 3 and 4 study. Kidney Int. 2002;62:1784–1790.

    Article  PubMed  Google Scholar 

  63. Mailloux LU, Haley WE. Hypertension in the ESRD patient: pathophysiology, therapy, outcomes, and future directions. Am J Kidney Dis. 1998;32:705–719.

    Article  PubMed  CAS  Google Scholar 

  64. Reiss U, Wingen AM, Schärer K. Mortality trends in pediatric patients with chronic renal failure. Pediatr Nephrol. 1996;10:602–605.

    Article  PubMed  CAS  Google Scholar 

  65. Groothoff JW, Gruppen MP, Offringa M, Hutten J, Lilien MR, Van De Kar NJ, Wolff ED, Davin JC, Heymans HS. Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int. 2002;61:621–629.

    Article  PubMed  Google Scholar 

  66. Parekh RS, Carroll CE, Wolfe RA, Port FK. Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr. 2002;141:191–197.

    Article  PubMed  CAS  Google Scholar 

  67. Wühl E, Frisch C, Schärer K, Mehls O. Assessment of total body water in pediatric patients on dialysis. Nephrol Dial Transplant. 1996;11:75–80.

    PubMed  Google Scholar 

  68. Dietel T, Filler G, Grenda R, Wolfish N. Bioimpedance and inferior vena cave diameter for assessment of dialysis dry weight. Pediatr Nephrol. 2000;14:903–907.

    Article  PubMed  CAS  Google Scholar 

  69. Patel HP, Goldstein SL, Mahan JD, Smith B, Fried CB, Currier H, Flynn JT. A standard, noninvasive monitoring of hematocrit algorithm improves blood pressure control in pediatric hemodialysis patients. Clin J Am Soc Nephrol. 2007;2:252–257.

    Article  PubMed  Google Scholar 

  70. Cheigh JS, Milite C, Sullivan JF, Rubin AL, Stenzel KH. Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis. 1992;19:453–459.

    PubMed  CAS  Google Scholar 

  71. Ifudu O. The concept of “dry weight” in maintenance hemodialysis: flaws in clinical application. Int J Artif. Organs. 1996;7:384–386.

    Google Scholar 

  72. Fagugli RM, Reboldi G, Quintalini G, Pasini P, Ciao G, Cicconi B, Pasticci F, Kaufman JM, Buoncristiani U. Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis. 2001;38:371–376.

    Article  PubMed  CAS  Google Scholar 

  73. Goldstein SL, Silverstein DM, Leung JC, Feig DI, Soletsky B, Knight C, Warady BA. Frequent hemodialysis with NxStage system in pediatric patients receiving maintenance hemodialysis. Pediatr Nephrol. 2008;23:129–135.

    Article  PubMed  Google Scholar 

  74. Krautzig S, Janssen U, Koch KM, Granolleeras S, Shaldon S. Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance hemodialysis patients. Nephrol Dial Transplant. 1998;13:552–553.

    Article  PubMed  CAS  Google Scholar 

  75. Feber J, Schärer K, Schaefer F, Míková M, Janda J. Residual renal function in children on haemodialyis and peritoneal dialysis therapy. Pediatr Nephrol. 1994;8:579–583.

    Article  PubMed  CAS  Google Scholar 

  76. Özkahya M, Ok E, Cirit M, Aydin S, Akcicek F, Basci A, Dorhout Mees EJ. Regression of left ventricular hypertrophy in hemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant. 1998;13:1489–1493.

    Article  PubMed  Google Scholar 

  77. Flanigan MJ, Khairullah QT, Lim VS. Dialysate sodium delivery can alter chronic blood pressure management. Am J Kidney Dis. 1997;29:383–391.

    Article  PubMed  CAS  Google Scholar 

  78. Kjeldsen SE. Julius S. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Am Heart J. 2004;148:747–754.

    Article  PubMed  CAS  Google Scholar 

  79. Baluarte HJ, Gruskin AB, Ingelfinger JR, Tejani A. Analysis of hypertension in children post renal transplantation—a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol. 1994;8:570–573.

    Article  PubMed  CAS  Google Scholar 

  80. Sorof JM, Sullivan EK, Tejani A, Portman RJ. Antihypertensive medication and renal allograft failure: A North American Pediatric Renal Transplant Cooperative Study report. J Am Soc Nephrol. 1999;10:1324–1330.

    PubMed  CAS  Google Scholar 

  81. Tutone VK, Mark PB, Stewart GA, Tan CC, Rodger RSC, Geddes CC, Jardine AG. Hypertension, antihypertensive agents and outcomes following renal transplantation. Clin Transplant. 2005;19:181–192.

    Article  PubMed  CAS  Google Scholar 

  82. Opelz G, Wujciak T, Ritz E for the Collaborative Transplant Study. Association of chronic kidney graft failure with recipient blood pressure. Kidney Int. 1998;53:217–222.

    Article  PubMed  CAS  Google Scholar 

  83. Mitsnefes MM, Omoloja A, McEnery PT. Short-term pediatric renal transplant survival: blood pressure and allograft function. Pediatr Transpl. 2001;5:160–165.

    Article  CAS  Google Scholar 

  84. Mitsnefes MM, Khoury PR, McEnery PT. Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr. 2003;143:98–103.

    Article  PubMed  Google Scholar 

  85. Mitsnefes MM, Portman RJ. Ambulatory blood pressure monitoring in pediatric renal transplantation. Pediatr Transplant. 2003;7:86–92.

    Article  PubMed  Google Scholar 

  86. Jacobi J, Rockstroh J, John S, Schreiber M, Schlaich MP, Neumayer HH, Schmieder RE. Prospective analysis of the value of 24-hour ambulatory blood pressure on renal function after kidney transplantation. Transplantation. 2000;70:819–827.

    Article  PubMed  CAS  Google Scholar 

  87. Morgan H, Khan I, Hashmi A, Hebert D, Balfe JW. Ambulatory blood pressure monitoring after renal transplantation in children. Pediatr Nephrol. 2001;16:843–847.

    Article  PubMed  CAS  Google Scholar 

  88. Seeman T, Šimková E, Kreisinger J, Vondrák K, Dušek J, Gilík J, Feber J, Dvořák P, Janda J. Control of hypertension in children after renal transplantation. Pediatr Transplant. 2006;10:316–322.

    Article  PubMed  CAS  Google Scholar 

  89. Lipkin GW, Tucker B, Giles M, Raine AE. Ambulatory blood pressure and left ventricular mass in cyclosporin- and non-cyclosporin-treated renal transplant recipients. J Hypertens. 1993;11:439–442.

    Article  PubMed  CAS  Google Scholar 

  90. McGlothan KR, Wyatt RJ, Ault BH, Hastings MC, Rogers T, DiSessa T, Jones DP. Predominance of nocturnal hypertension in pediatric renal allograft recipients. Pediatr Transplant. 2006;10:558–564.

    Article  PubMed  Google Scholar 

  91. Vianello A, Mastrosimone S, Calconi G, Gatti PL, Calzavara P, Maresca MC. The role of hypertension as damaging factor for kidney grafts under cyclosporine therapy. Am J Kidney Dis. 1993;21(Suppl 1):79–83.

    PubMed  CAS  Google Scholar 

  92. Gordjani A, Offner G, Hoyer PF, Brodehl J. Hypertension after renal transplantation in patients treated with cyclosporine and azathioprine. Arch Dis Child. 1990;65:275–279.

    Article  PubMed  CAS  Google Scholar 

  93. El-Husseini AA, Foda MA, Shokeir AA, Shebab El-Din AB, Sobh MA, Ghoneim MA. Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: a single center experience. Pediatr Transplant. 2005;9:763–760.

    Article  PubMed  Google Scholar 

  94. Kasiske BL, Ballantyne CM. Cardiovascular risk associated with immunosuppression in renal transplantation. Transplant Rev. 2002;16:1–21.

    Article  Google Scholar 

  95. Hocker B, John U, Plank C, Wuhl E, Weber LT, Misselwitz J, Rascher W, Mehls O, Tonshoff B. Successful withdrawal of steroids in pediatrics renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years. Transplantation. 2004;78:228–234.

    Article  PubMed  Google Scholar 

  96. Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O Jr. Continued superior outcome with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation. 2003;76:1331–1339.

    Article  PubMed  CAS  Google Scholar 

  97. Curtis JJ, Galla JH, Kotchen TA, Lucas B, McRoberts JW, Luke RG. Prevalence of hypertension in a renal transplant population on alternate-day steroid therapy. Clin Nephrol. 1976;5:123–127.

    PubMed  CAS  Google Scholar 

  98. Büscher R, Vester U, Wingen AM, Hoyer PF. Pathomechanisms and the diagnosis of arterial hypertension in pediatric renal allograft recipients. Pediatr Nephrol. 2004;19:1202–1211.

    Article  PubMed  Google Scholar 

  99. Trompeter R, Filler G, Webb NJ, Watson AR, Milford DV, Tyden G, Grenda R, Janda J, Hughes D, Ehrich JH, Klare B, Zacchello G, Bjorn Brekke I, McGraw M, Perner F, Ghio L, Balzar E, Friman S, Gusmano R, Stolpe J. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol. 2002;17:141–149.

    Article  PubMed  Google Scholar 

  100. Cheigh JS, Haschemeyer RH, Wang JCL, Riggio RR, Tapia L, Stenzel KH, Rubin AL. Hypertension in kidney transplant recipients. Effect on long-term renal allograft survival. Am J Hypertens. 1989;2:341–348.

    PubMed  CAS  Google Scholar 

  101. Lurbe E, Alvarez V, Liao Y, Tacons J, Cooper R, Cremades B, Torro I, Redon J. The impact of obesity and body fat distribution on ambulatory blood pressure in children and adolescents. Am J Hypertens. 1998;11:418–424.

    Article  PubMed  CAS  Google Scholar 

  102. Hanevold CD, Ho PL, Talley L, Mitsnefes MM. Obesity and renal transplant outcome: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics. 2005;115:352–356.

    Article  PubMed  Google Scholar 

  103. Fung LC, McLorie GA, Khoury AR. Donor aortic cuff reduces the rate of anastomotic arterial stenosis in pediatric renal transplantation. J Urol. 1995;154:909–913.

    Article  PubMed  CAS  Google Scholar 

  104. Matteucci MC, Giordano U, Calzolari A, Turchetta A, Santilli A, Rizzoni G. Left ventricular hypertrophy, treadmill tests, and 24-hour blood pressure in pediatric transplant patients. Kidney Int. 1999;56:1566–1570.

    Article  PubMed  CAS  Google Scholar 

  105. Kitzmueller E, Vécsei A, Pichler J, Bohm M, Muller T, Vargha R, Csaicsich D, Aufricht C. Changes of blood pressure and left ventricular mass in pediatric renal transplantation. Pediatr Nephrol. 2004;19:1385–1389.

    Article  PubMed  Google Scholar 

  106. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol. 1996;7:158–165.

    PubMed  CAS  Google Scholar 

  107. Curtis JJ. Treatment of hypertension in renal allograft patients: Does drug selection make a difference. Kidney Int. 1997;52(Suppl 63):S75–S77.

    Google Scholar 

  108. Stigant CE, Cohen J, Vivera M, Zaltzman JS. ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy. Am J Kidney Dis. 2000;35:58–63.

    Article  PubMed  CAS  Google Scholar 

  109. Arbeiter K, Pichler A, Stemberger R, Mueller T, Ruffingshofer D, Vargha R, Balzar E, Aufricht C. ACE inhibition in the treatment of children after renal transplantation. Pediatr Nephrol. 2004;19:222–226.

    Article  PubMed  Google Scholar 

  110. Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol. 2006;17:889–899.

    Article  PubMed  CAS  Google Scholar 

  111. Opelz G, Zeier M, Laux G, Morath C, Dohler B. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report. J Am Soc Nephrol. 2006;17:3257–3262.

    Article  PubMed  CAS  Google Scholar 

  112. Calvino J, Lens XM, Romero R, Sánchez-Guisande D. Long-term anti-proteinuric effect of losartan in renal transplant recipients treated for hypertension. Nephrol Dial Transplant. 2000;15:82–86.

    Article  PubMed  CAS  Google Scholar 

  113. Hausberg M, Barenbrock M, Hohage H, Müller S, Heidenreich S, Rahn KH. ACE inhibitor versus β-blocker for the treatment of hypertension in renal allograft recipients. Hypertension. 1999;33:862–868.

    PubMed  Google Scholar 

  114. Task force on cardiovascular disease. Special report from the National Kidney Foundation. Am J Kidney Dis. 1998;32(Suppl 3):1–121.

    Google Scholar 

  115. Schaefer F. Intensified blood pressure control in pediatric chronic kidney disease: results of the ESCAPE trial. Pediatr Nephrol. 2007;22:1415.

    Google Scholar 

  116. Flynn JT. Hypertension and future cardiovascular disease in pediatric renal transplant recipients. Pediatr Transplant. 2006;10:276–278.

    Article  PubMed  Google Scholar 

  117. Opelz G, Dohler B. Collaborative Transplant Study. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant. 2005;5:2725–2731.

    Article  PubMed  Google Scholar 

  118. Seeman T, Šimková E, Kreisinger J, Vondrák K, Dušek J, Gilík J, Dvořák P, Janda J. Improved control of hypertension in children after renal transplantation: Results of a two-yr interventional trial. Pediatr Transplant. 2007;11:491–497.

    Article  PubMed  CAS  Google Scholar 

  119. Becker-Cohen R, Nir A, Ben-Shalom E, Rinat C, Feinstein S, Farber B, Frishberg Y. Improved left ventricular mass index in children after renal transplantation. Pediatr Nephrol. 2008;23:1545–1550.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Supported by the Ministry of Education of the Czech Republic VZ MŠMT No 0021620819 and Ministry of Health VZ MZ No 0006420301, MZOFNM2005.

Author information

Authors and Affiliations

  1. Department of Pediatrics, 2nd Faculty of Medicine, University Hospital Motol, Charles University Prague, Prague, Czech Republic

    Tomáš Seeman MD, PhD

Authors
  1. Tomáš Seeman MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tomáš Seeman MD, PhD .

Editor information

Editors and Affiliations

  1. , Division of Nephrology, Seattle Children's Hospital, Sand Point Way NE. 4800, Seattle, 98105, Washington, USA

    Joseph T. Flynn

  2. Massachusetts General Hospital, Fruit St. 55, Boston, 02114, Massachusetts, USA

    Julie R. Ingelfinger

  3. Global Clinical Research, Bristol-Myers Squibb, Route 206 & Provinceline Road, Princeton, 08543, New Jersey, USA

    Ronald J. Portman

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Seeman, T. (2011). Hypertension in End-Stage Renal Disease. In: Flynn, J., Ingelfinger, J., Portman, R. (eds) Pediatric Hypertension. Clinical Hypertension and Vascular Diseases. Humana Press. https://doi.org/10.1007/978-1-60327-824-9_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-824-9_23

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-823-2

  • Online ISBN: 978-1-60327-824-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation